Caribou Biosciences, Inc. CRBU
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-23
Caribou Biosciences, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 6,947,820 | $11.4M |
| RENAISSANCE TECHNOLOGIES LLC | 2,590,497 | $4.9M |
| TWO SIGMA INVESTMENTS, LP | 1,759,934 | $3.3M |
| MILLENNIUM MANAGEMENT LLC | 1,074,421 | $2.0M |
| CITADEL ADVISORS LLC | 297,933 | $566,073 |
| Point72 Asset Management, L.P. | 187,622 | $356,482 |
| AQR CAPITAL MANAGEMENT LLC | 15,678 | $29,788 |
Source: SEC EDGAR filings · CIK 0001619856 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.